Coronavirus India Highlights: Indian vaccine manufacturer Bharat Biotech’s intranasal Covid-19 vaccine has received the regulatory approval for mid- to late-stage trials, the government’s ministry of science and technology said in a statement on Friday. This is the first of its kind Covid-19 jab to undergo human clinical trials in India.
Mumbai has recorded its first death due to the Delta Plus variant of Covid-19 with a 63-year-old woman in Ghatkopar succumbing to it in July. This is the second Delta Plus death in Maharashtra, the first being an 80-year-old woman from Ratnagiri, who succumbed to the disease on June 13. Delta Plus is a mutation of the highly transmissible Delta variant of Sars-CoV-2 (B.1.617.2).
India recorded 40,120 new covid-19 infections in the 24 hours ending 8 am Friday, taking the country’s tally to over 3.21 crore. Out of the new cases, active cases have come down to 3.85 lakh while recoveries have risen to 3.13 crore. Kerala continues to top the charts with 21,445 infections. The country recorded 585 deaths, the total toll now exceeds 4.3 lakh.
Meanwhile, no death due to COVID-19 was recorded in Delhi on Thursday, the second consecutive day when the daily fatality count was nil, while 49 fresh cases were reported with a positivity rate of 0.07 per cent, according to data shared by the city health department. This is the eight time, since the starting of the second wave of the pandemic in the national capital, that zero fatality has been logged in a day.